XML 46 R36.htm IDEA: XBRL DOCUMENT v3.22.4
Joint Venture (Tables)
6 Months Ended
Dec. 31, 2022
Equity Method Investments and Joint Ventures [Abstract]  
Summary of Reconciliation Between the Carrying Value of Investment and Proportional Share of Underlying Equity in Net Assets of Joint Ventures

The following table shows the reconciliation between the carrying value of the Company's investment in the JV and its proportional share of the underlying equity in net assets of the JV (in thousands):

 

 

 

December 31,
 2022

 

 

June 30,
2022

 

Carrying value of investment in joint venture

 

$

12,276

 

 

$

13,879

 

Deferred intra-entity profit margin

 

 

4,469

 

 

 

5,456

 

Equity method goodwill

 

 

(4,720

)

 

 

(4,720

)

Proportional share of equity investment in joint venture

 

$

12,025

 

 

$

14,615

 

 

Summary of Financial Information of Joint Ventures (Operations Data)

Summarized financial information of the JV, based on a one-quarter lag due to the timing of the availability of the JV’s financial records, is as follows (in thousands):

 

 

 

Three Months Ended
September 30,

 

 

Six Months Ended
September 30,

 

Statement of Operations Data:

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Revenue

 

$

23,983

 

 

$

8,123

 

 

$

50,723

 

 

$

15,792

 

Gross Profit

 

 

3,719

 

 

 

2,602

 

 

 

8,315

 

 

 

4,942

 

Net loss

 

 

(1,416

)

 

 

(1,698

)

 

 

(2,168

)

 

 

(2,391

)

Net loss attributable to the Company

 

 

(699

)

 

 

(832

)

 

 

(1,067

)

 

 

(1,172

)

Summary of Financial Information of Joint Ventures (Balance Sheet Data)

Summarized Balance Sheet Data:

 

As of
September 30, 2022

 

 

As of
September 30, 2021

 

Assets

 

 

 

 

 

 

Current assets

 

$

74,525

 

 

$

59,250

 

Non-current assets

 

 

17,658

 

 

 

22,677

 

Total assets

 

$

92,183

 

 

$

81,927

 

Liabilities and Stockholders' Equity

 

 

 

 

 

 

Current liabilities

 

$

66,618

 

 

$

53,700

 

Non-current liabilities

 

 

669

 

 

 

1,147

 

Stockholders' equity

 

 

24,896

 

 

 

27,080

 

Total liabilities and stockholders' equity

 

$

92,183

 

 

$

81,927

 

Schedule of Deferred Intra Entity Profit Margin from Sales

The following table shows the activity of the Company’s deferred intra-entity profit margin from sales (in thousands):

 

 

 

Three Months Ended
December 31,

 

 

Six Months Ended
December 31,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Previously deferred intra-entity profit margin from sales - recognized

 

$

(4,067

)

 

$

(1,002

)

 

$

(6,415

)

 

$

(1,217

)

Intra-entity profit margin from sales - deferred

 

 

3,042

 

 

 

219

 

 

 

5,429

 

 

 

2,172

 

Total change in deferred intra-entity profit margin from sales

 

$

(1,025

)

 

$

(783

)

 

$

(986

)

 

$

955